Filter Results :

Your search for T-cell returned 28 reports

Sort by


Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H2, 2017

19 Jul 2017  |  Published by:  GlobalData
Summary"Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview of Cutaneous T-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous T-Cell Lymphoma. Report includes an overview of trial numbers and the...

$ 2,500.00

Read More

2017 Global and Regional T-Cell Immunotherapy Market Research Report Forecasts 2022

09 Jul 2017  |  Published by:  Tuoda Research
This report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding C...

$ 2,800.00

Read More

Peripheral T-Cell Lymphoma (PTCL) - Market Insights, Epidemiology and Market Forecast-2025

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s “Peripheral T-Cell Lymphoma (PTCL) - Market Insights, Epidemiology and Market Forecast – 2025” Reports provides an overview of the disease and global market size of the Peripheral T-Cell Lymphoma (PTCL) for the 7MM (United States, Germany, France, Italy, Spain and UK). The Report cove...

$ 5,750.00
$ 4,600.00
( Save 20% )

Read More

Peripheral T-Cell Lymphoma (PTCL)- Epidemiology Insights to 2025

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight “ Peripheral T-Cell Lymphoma (PTCL) - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Peripheral T-Cell Lymphoma (PTCL) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted...

$ 2,950.00
$ 2,360.00
( Save 20% )

Read More

Peripheral T-Cell Lymphoma - Competitive Landscape, Market Insights, Epidemiology and Market Forecast - 2023

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s ‘Peripheral T-Cell Lymphoma (PTCL) - Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2025’ report provides provides the comprehensive insights on the competitive landscape and market of Peripheral T-Cell Lymphoma (PTCL).The report covers an overview of the Per...

$ 6,950.00
$ 5,560.00
( Save 20% )

Read More

Peripheral T-Cell Lymphomas (PTCL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s, Peripheral T-Cell Lymphomas (PTCL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Peripheral T-Cell Lymphomas (PTCL). The report includes information of marketed products i...

$ 2,250.00
$ 1,800.00
( Save 20% )

Read More

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insights, 2017

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s, “Peripheral T-Cell Lymphoma (PTCL)-Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Peripheral T-Cell Lymphoma (PTCL...

$ 1,250.00
$ 1,000.00
( Save 20% )

Read More

Cutaneous T-Cell Lymphoma - Competitive Landscape, Market Insights, Epidemiology and Market Forecast - 2025

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s “Cutaneous T-Cell Lymphoma – Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2025”report provides an overview of the disease, the comprehensive insights on the competitive landscape and market of Cutaneous T-Cell Lymphoma.The Report covers detailed historical ...

$ 6,950.00
$ 5,560.00
( Save 20% )

Read More

Cutaneous T-Cell Lymphoma(CTCL) - Market Insights, Epidemiology and Market Forecast-2025

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s “Cutaneous T-Cell Lymphoma(CTCL) - Market Insights, Epidemiology and Market Forecast – 2025” Reports provides an overview of the disease and global market size of the Cutaneous T-Cell Lymphoma(CTCL) for the 7MM (United States, Germany, France, Italy, Spain and UK). The Report covers t...

$ 5,750.00
$ 4,600.00
( Save 20% )

Read More

Cutaneous T-Cell Lymphoma(CTCL)- Epidemiology Insights to 2025

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight “ Cutaneous T-Cell Lymphoma(CTCL) - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Cutaneous T-Cell Lymphoma(CTCL) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted dat...

$ 2,950.00
$ 2,360.00
( Save 20% )

Read More

Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Cutaneous T-Cell Lymphoma Report is to...

$ 2,000.00
$ 1,600.00
( Save 20% )

Read More

Cutaneous T-Cell Lymphoma-Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s, “ Cutaneous T-Cell Lymphoma-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Cutaneous T-Cell Lymphoma. The DelveInsight’sReport covers the product profiles in various stages of development including Discove...

$ 1,250.00
$ 1,000.00
( Save 20% )

Read More

T-Cell Leukemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jun 2017  |  Published by:  DelveInsight
Summary'T-Cell Leukemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufac...

$ 2,000.00
$ 1,600.00
( Save 20% )

Read More

T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the T-Cell Leukemia Report is to understand the mark...

$ 2,000.00
$ 1,600.00
( Save 20% )

Read More

T-Cell Leukemia-Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s, “ T-Cell Leukemia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the T-Cell Leukemia. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IN...

$ 1,250.00
$ 1,000.00
( Save 20% )

Read More
Total 28 records.